CTOR

NASD Citius Oncology, Inc.
Nov 3, 2026 · 7:29 AM ET LAST TRADE Market Closed

$0.5941 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.5941

YTD change
-40.59%
vs 20-day SMA
-15.73%
vs 200-day SMA
-28.64%

Price ranges

Previous day
$0.5535 $0.6940
open $0.5890 close $0.5941
+$0.0051 (+0.87%)
Today
$0.0000 $0.0000
$0.5941
Past week
$0.5001 $0.6940
from $0.5957 now $0.5941
-$0.0016 (-0.27%)
Past month
$0.5001 $0.9199
from $0.8735 now $0.5941
-$0.2794 (-31.99%)
This year
$0.4912 $1.2600
from $1.0000 now $0.5941
-$0.4059 (-40.59%)

Price & Performance

-0.33 (-35.42%) / 6M

$0.4807$0.7167$0.9528$1.19May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 90.4% away from all-time highs of $6.1900
  • CTOR is down 41% since the beginning of the year
  • CTOR is down 64% over the past 12 months
  • CTOR is down 32% over the past 1 month
  • 0% of all CTOR investors are betting against CTOR

CTOR reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -64.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.08
Earnings momentum -14.3% Quarterly EPS growth
Quarterly change -14.3%

Valuation

P/E ratio N/A
Enterprise value $57.7M
Beta 4.32

Balance sheet & scale

IncomeN/A
Revenue$7.2M
Cash$16.6M
Debt$10.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $67.0M

Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.